
Zenlabs Ethica (ZENLABS) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
129.9M
Gross Profit
42.8M
32.99%
Operating Income
3.4M
2.62%
Net Income
906.0K
0.70%
Balance Sheet Metrics
Total Assets
406.2M
Total Liabilities
302.0M
Shareholders Equity
104.2M
Debt to Equity
2.90
Cash Flow Metrics
Revenue & Profitability Trend
Zenlabs Ethica Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 514.2M | 585.6M | 668.9M | 690.9M | 566.4M |
Cost of Goods Sold | 372.2M | 437.9M | 533.0M | 563.9M | 467.3M |
Gross Profit | 142.0M | 147.8M | 135.8M | 126.9M | 99.1M |
Gross Margin % | 27.6% | 25.2% | 20.3% | 18.4% | 17.5% |
Operating Expenses | |||||
Research & Development | - | - | - | - | 339.6K |
Selling, General & Administrative | - | 35.6M | 31.0M | 32.4M | 26.5M |
Other Operating Expenses | 74.3M | 43.5M | 32.4M | 28.8M | 18.1M |
Total Operating Expenses | 74.3M | 79.1M | 63.4M | 61.3M | 45.0M |
Operating Income | 13.1M | 11.2M | 16.6M | 15.0M | 10.4M |
Operating Margin % | 2.5% | 1.9% | 2.5% | 2.2% | 1.8% |
Non-Operating Items | |||||
Interest Income | - | 585.0K | 831.0K | 849.0K | 957.0K |
Interest Expense | 9.3M | 8.0M | 5.3M | 3.6M | 2.8M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 4.3M | 5.8M | 6.7M | 12.2M | 8.6M |
Income Tax | 1.6M | 1.6M | 1.9M | 4.4M | 926.0K |
Effective Tax Rate % | 37.1% | 27.6% | 27.5% | 36.0% | 10.8% |
Net Income | 2.7M | 4.2M | 4.9M | 7.8M | 7.7M |
Net Margin % | 0.5% | 0.7% | 0.7% | 1.1% | 1.4% |
Key Metrics | |||||
EBITDA | 26.2M | 24.6M | 30.3M | 24.8M | 18.7M |
EPS (Basic) | - | ₹0.65 | ₹0.75 | ₹1.20 | ₹1.18 |
EPS (Diluted) | - | ₹0.65 | ₹0.75 | ₹1.20 | ₹1.18 |
Basic Shares Outstanding | - | 6510015 | 6510015 | 6510015 | 6510015 |
Diluted Shares Outstanding | - | 6510015 | 6510015 | 6510015 | 6510015 |
Income Statement Trend
Zenlabs Ethica Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 17.9M | 9.0M | 545.0K | 93.0K | 882.0K |
Short-term Investments | 2.3M | 2.4M | 3.2M | 678.0K | 1.3M |
Accounts Receivable | 195.4M | 207.3M | 217.0M | 207.4M | 188.8M |
Inventory | 131.0M | 120.0M | 113.7M | 86.6M | 51.8M |
Other Current Assets | 27.0M | 16.8M | 20.9M | 23.5M | 20.2M |
Total Current Assets | 373.5M | 355.5M | 375.0M | 334.0M | 274.9M |
Non-Current Assets | |||||
Property, Plant & Equipment | 22.9M | 2.1M | 2.1M | 2.1M | 2.1M |
Goodwill | - | - | - | - | 0 |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | 80.0K | - | 6 |
Total Non-Current Assets | 32.7M | 47.1M | 59.9M | 45.0M | 47.1M |
Total Assets | 406.2M | 402.6M | 434.9M | 379.0M | 322.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 142.8M | 121.4M | 254.2M | 218.3M | 192.4M |
Short-term Debt | 121.3M | 132.7M | 28.2M | 18.2M | 7.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 2.9M | 3.4M | 824.0K | 1.1M | 730.0K |
Total Current Liabilities | 281.2M | 270.2M | 294.5M | 252.0M | 214.5M |
Non-Current Liabilities | |||||
Long-term Debt | 5.7M | 15.9M | 30.3M | 20.8M | 19.0M |
Deferred Tax Liabilities | - | - | - | - | 0 |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 20.7M | 31.1M | 43.4M | 33.6M | 21.8M |
Total Liabilities | 302.0M | 301.4M | 337.9M | 285.6M | 236.4M |
Equity | |||||
Common Stock | 65.1M | 65.1M | 65.1M | 65.1M | 65.1M |
Retained Earnings | - | 36.1M | 31.9M | 28.2M | 20.3M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 104.2M | 101.2M | 97.0M | 93.3M | 85.6M |
Key Metrics | |||||
Total Debt | 127.0M | 148.6M | 58.4M | 39.0M | 26.0M |
Working Capital | 92.3M | 85.2M | 80.5M | 82.0M | 60.4M |
Balance Sheet Composition
Zenlabs Ethica Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 4.3M | 5.8M | 6.7M | 12.2M | 8.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -8.7M | 16.0M | -48.3M | -53.0M | -132.6M |
Operating Cash Flow | 4.8M | 29.5M | -31.3M | -37.9M | -122.1M |
Investing Activities | |||||
Capital Expenditures | 1.5M | - | - | 0 | 600.0K |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | 1.5M | - | - | 0 | 601.0K |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | -1.6M | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | -7.8M | 103.3M | 2.5M | 12.6M | -10 |
Free Cash Flow | 38.1M | -90.8M | -264.0K | -4.1M | -84.1M |
Net Change in Cash | -1.5M | 132.9M | -28.8M | -25.3M | -121.5M |
Cash Flow Trend
Zenlabs Ethica Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
78.02
Price to Book
1.99
Price to Sales
0.42
Profitability Ratios
Profit Margin
0.52%
Operating Margin
2.62%
Return on Equity
2.62%
Return on Assets
2.02%
Financial Health
Current Ratio
1.33
Debt to Equity
121.85
Beta
-0.77
Per Share Data
EPS (TTM)
₹0.41
Book Value per Share
₹16.09
Revenue per Share
₹78.32
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
zenlabs | 214.6M | 78.02 | 1.99 | 2.62% | 0.52% | 121.85 |
Entero Healthcare | 51.9B | 54.82 | 3.01 | 5.36% | 1.90% | 21.76 |
Amwill Health Care | 1.2B | 8.97 | 1.72 | 24.85% | 26.44% | 0.00 |
Royal Sense | 1.1B | 17.33 | 3.62 | 27.55% | 10.26% | 11.74 |
NOVELIX | 532.4M | 514.50 | 2.34 | 0.68% | 0.28% | 0.00 |
Trimurthi | 264.8M | 102.35 | 2.40 | 0.00% | 1.85% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.